EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nanobodies Are Potential Therapeutic Agents for the Ebola Virus Infection

I B Esmagambetov, D V Shcheblyakov, D A Egorova, O L Voronina, A A Derkaev, D V Voronina, O Popova, E I Ryabova, D N Shcherbinin, E I Aksenova, A N Semenov, M S Kunda und 7 weitere

Acta Naturae · 2021

DOI: 10.32607/actanaturae.11487 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Naturae, 2021. Verfasst von I B Esmagambetov und 18 weiteren Autor:innen. Beteiligte Einrichtung: Federal State Budgetary Institution "National Research Centre for Epidemiology and Microbiology named after the Honorary Academician N. F. Gamaleya" …. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ebola fever is an acute, highly contagious viral disease with a mortality rate that can reach 90%. There are currently no licensed therapeutic agents specific to Ebola in the world. Monoclonal antibodies (MAbs) with viral-neutralizing activity and high specificity to the Ebola virus glycoprotein (EBOV GP) are considered as highly effective potential antiviral drugs. Over the past decade, nanobodies (single-domain antibodies, non-canonical camelid antibodies) have found wide use in the diagnosis and treatment of various infectious and non-infectious diseases. In this study, a panel of nanobodies specifically binding to EBOV GP was obtained using recombinant human adenovirus 5, expressing GP (Ad5-GP) for alpaca (Vicugna pacos) immunization, for the first time. Based on specific activity assay results, affinity constants, and the virus-neutralizing activity against the recombinant vesicular stomatitis virus pseudotyped with EBOV GP (rVSV-GP), the most promising clone (aEv6) was selected. The aEv6 clone was then modified with the human IgG1 Fc fragment to improve its pharmacokinetic and immunologic properties. To assess the protective activity of the chimeric molecule aEv6Fc, a lethal model of murine rVSV-GP infection was developed by using immunosuppression. The results obtained in lethal model mice have demonstrated the protective effect of aEv6Fc. Thus, the nanobody and its modified derivative obtained in this study have shown potential protective value against Ebola virus.

Schlagwörter

Stichwörter der Autor:innen

Ebola virusnanobodyrecombinant adenoviral vectorrecombinant vesicular stomatitis virus

Autor:innen und Institutionen

  • Federal State Budgetary Institution "National Research Centre for Epidemiology and Microbiology named after the Honorary Academician N. F. Gamaleya" of the Ministry of Health of the Russian Federation, Moscow, 123098 Ru…
  • 48 Central Research Institute, Ministry of Defense, Sergiev Posad-6, 141306 Russia.

Zitieren

APA

Esmagambetov, I. B., Shcheblyakov, D. V., Egorova, D. A., Voronina, O. L., Derkaev, A. A., Voronina, D. V., Popova, O., Ryabova, E. I., Shcherbinin, D. N., Aksenova, E. I., Semenov, A. N., Kunda, M. S., Ryzhova, N. N., Zubkova, O. V., Tukhvatulin, A. I., Logunov, D. Y., Naroditsky, B. S., Borisevich, S. V., & Gintsburg, A. L. (2021). Nanobodies Are Potential Therapeutic Agents for the Ebola Virus Infection. Acta Naturae. https://doi.org/10.32607/actanaturae.11487

Vancouver

Esmagambetov IB, Shcheblyakov DV, Egorova DA, Voronina OL, Derkaev AA, Voronina DV, et al. Nanobodies Are Potential Therapeutic Agents for the Ebola Virus Infection. Acta Naturae. 2021. doi:10.32607/actanaturae.11487

BibTeX
@article{Esmagambetov2021,
  author = {Esmagambetov, I B and Shcheblyakov, D V and Egorova, D A and Voronina, O L and Derkaev, A A and Voronina, D V and Popova, O and Ryabova, E I and Shcherbinin, D N and Aksenova, E I and Semenov, A N and Kunda, M S and Ryzhova, N N and Zubkova, O V and Tukhvatulin, A I and Logunov, D Yu and Naroditsky, B S and Borisevich, S V and Gintsburg, A L},
  title = {Nanobodies Are Potential Therapeutic Agents for the Ebola Virus Infection},
  journal = {Acta Naturae},
  year = {2021},
  doi = {10.32607/actanaturae.11487}
}
Kostenlos starten →